Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Seattle, WA
SEC filing record 1 source field available
Fiscal year end
31 December
CTI BIOPHARMA CORP has filed 2,393 SEC EDGAR filings since 27 Jun 1996

SEC filing history

Showing 126-150 of 1,000 matching filings.

Per page
25
Current page
6
SC TO-C File 005-48459

SC TO-C

Filing date
10 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC14D9C File 005-48459

SC14D9C

Filing date
10 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC14D9C File 005-48459

SC14D9C

Filing date
10 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 000-28386

ARS

Filing date
28 Apr 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-28386

DEFA14A

Filing date
28 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-28386

DEF 14A

Filing date
28 Apr 2023
Reporting date
21 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-48459

SC 13G filing

Filing date
13 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Apr 2023
Reporting date
05 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Apr 2023
Reporting date
05 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Apr 2023
Reporting date
05 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Apr 2023
Reporting date
05 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Apr 2023
Reporting date
05 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Apr 2023
Reporting date
05 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
07 Apr 2023
Reporting date
05 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-48459

SC 13G filing

Filing date
24 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Mar 2023
Reporting date
14 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Mar 2023
Reporting date
14 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Mar 2023
Reporting date
14 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5 SUBMISSION

Filing date
14 Feb 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-48459

SC 13G/A filing

Filing date
13 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-48459

SC 13G/A filing

Filing date
03 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-48459

SC 13G filing

Filing date
03 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .